These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 14561846
21. Genetic mutations and arrhythmia: simulation from DNA to electrocardiogram. Zhu ZI, Clancy CE. J Electrocardiol; 2007; 40(6 Suppl):S47-50. PubMed ID: 17993328 [Abstract] [Full Text] [Related]
22. Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias. Dai DZ, Yu F. Acta Pharmacol Sin; 2005 Aug; 26(8):918-25. PubMed ID: 16038623 [Abstract] [Full Text] [Related]
23. Molecular basis of arrhythmias. Shah M, Akar FG, Tomaselli GF. Circulation; 2005 Oct 18; 112(16):2517-29. PubMed ID: 16230503 [Abstract] [Full Text] [Related]
24. Drug-induced QT prolongation and proarrhythmia: an inevitable link? Ahmad K, Dorian P. Europace; 2007 Sep 18; 9 Suppl 4():iv16-22. PubMed ID: 17766320 [Abstract] [Full Text] [Related]
25. Ion channel diseases in children: manifestations and management. Schwartz PJ, Crotti L. Curr Opin Cardiol; 2008 May 18; 23(3):184-91. PubMed ID: 18382205 [Abstract] [Full Text] [Related]
26. Two patterns of ion channelopathy in the myocardium: perspectives for development of anti-arrhythmic agents. Dai DZ. Curr Opin Investig Drugs; 2005 Mar 18; 6(3):289-97. PubMed ID: 15816506 [Abstract] [Full Text] [Related]
27. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death]. Kecskeméti V. Neuropsychopharmacol Hung; 2004 Mar 18; 6(1):5-12. PubMed ID: 15125308 [Abstract] [Full Text] [Related]
28. [HERG K+ channel, the target of anti-arrhythmias drugs]. Guan FY, Yang SJ. Yao Xue Xue Bao; 2007 Jul 18; 42(7):687-91. PubMed ID: 17882949 [Abstract] [Full Text] [Related]
29. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Ohno S, Toyoda F, Zankov DP, Yoshida H, Makiyama T, Tsuji K, Honda T, Obayashi K, Ueyama H, Shimizu W, Miyamoto Y, Kamakura S, Matsuura H, Kita T, Horie M. Hum Mutat; 2009 Apr 18; 30(4):557-63. PubMed ID: 19306396 [Abstract] [Full Text] [Related]
30. Susceptibility genes and modifiers for cardiac arrhythmias. Kääb S, Schulze-Bahr E. Cardiovasc Res; 2005 Aug 15; 67(3):397-413. PubMed ID: 15949790 [Abstract] [Full Text] [Related]
31. Ion channels and diseases. Hatta S, Sakamoto J, Horio Y. Med Electron Microsc; 2002 Sep 15; 35(3):117-26. PubMed ID: 12353132 [Abstract] [Full Text] [Related]
32. The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? Scicluna BP, Wilde AA, Bezzina CR. J Cardiovasc Electrophysiol; 2008 Apr 15; 19(4):445-52. PubMed ID: 18284507 [Abstract] [Full Text] [Related]
33. Genomics and cardiac arrhythmias. Roberts R. J Am Coll Cardiol; 2006 Jan 03; 47(1):9-21. PubMed ID: 16386658 [Abstract] [Full Text] [Related]
34. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Wood DM, Dargan PI, Hoffman RS. Clin Toxicol (Phila); 2009 Jan 03; 47(1):14-23. PubMed ID: 18815938 [Abstract] [Full Text] [Related]
35. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM. Curr Opin Investig Drugs; 2006 Mar 03; 7(3):256-63. PubMed ID: 16555686 [Abstract] [Full Text] [Related]